GlassScriptPhysician profile
John Blake Boyett
NPI 1114209541
$157,748.56
in general payments reported to CMS, 2019-2025
25 companies · $57K in 2025
The $57K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $15K · 2021: $11K · 2022: $23K · 2023: $19K · 2024: $22K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $22K · Food and Beverage: $8,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $68,200.00 |
| Travel and Lodging | $21,642.28 |
| Food and Beverage | $8,553.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $78,309.26 | 2024-2025 | Xlif, Anthem, Alif |
| Nuvasive, INC. | $75,046.99 | 2019-2023 | Xlif, Pulse, Tlif |
| Zavation Medical Products, LLC | $1,000.00 | 2023 | |
| Providence Medical Technology, INC. | $941.14 | 2021-2025 | |
| Orthofix Medical, INC. | $616.69 | 2019-2025 | Spinal-Stim, Spinal-Stim |
| Boston Scientific Corporation | $505.50 | 2021-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Nevro Corp. | $341.81 | 2020-2024 | Senza |
| Carlsmed, INC. | $232.70 | 2024 | Aprevo |
| Si-Bone, INC. | $167.41 | 2020-2023 | |
| Mml US, INC. | $136.95 | 2023 | Reactiv8 |
| Ferring Pharmaceuticals INC. | $124.00 | 2019 | |
| Saluda Medical Americas, INC. | $44.20 | 2023 | Evoke Scs |
| Relievant Medsystems, INC. | $40.25 | 2020 | |
| Olympus America INC. | $30.29 | 2019 | |
| Radius Health, INC. | $28.75 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $28.56 | 2024 | Arthrex |
| Depuy Synthes Sales INC. | $21.92 | 2019 | |
| Kci USA, INC. | $20.03 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.49 | 2023 | Exparel, Iovera |
| Bioventus LLC | $17.72 | 2023 | Bonescalpel |
| Abbott Laboratories | $17.12 | 2022 | |
| Integra Lifesciences Corporation | $16.61 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2022 | |
| Heron Therapeutics, INC. | $13.49 | 2022 | |
| Misonix INC | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boyett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.